Michael R. Lassen

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

Michael R. Lassen, Walter Ageno, Lars C. Borris et al. · New England Journal of Medicine · 2008 · 1.3K citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

Alexander GG Turpie, Michael R. Lassen, Bruce L. Davidson et al. · The Lancet · 2009 · 979 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

Alexander T Cohen, Bruce L. Davidson, Alexander Gallus et al. · BMJ · 2006 · 861 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +12

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Michael R. Lassen, Gary E. Raskob, Alexander Gallus et al. · The Lancet · 2010 · 777 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

Michael R. Lassen, Alexander Gallus, Gary E. Raskob et al. · New England Journal of Medicine · 2010 · 775 citations

Medicine, Pharmacology, Pharmacotherapy +17